Elevance Health Inc.
Rating
Updated: Sep 1, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to v...
Latest News
11 days ago · benzinga.com
Elevance Health Stock is Moving Higher After FY26 EPS ReaffirmationElevance Health Inc. (NYSE:ELV) shares are jumping Thursday after the company reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings. Here's what you should know.
27 days ago · gurufocus.com
Is ELV Undervalued? DCF Says Worth $614On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to
1 month ago · defenseworld.net
Barden Capital Management Inc. Purchases New Stake in Elevance Health, Inc. $ELVBarden Capital Management Inc. acquired a new position in Elevance Health, Inc. (NYSE: ELV) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,609 shares of the company's stock, valued at approximately $622,000. A number of other institutional investors
1 month ago · zacks.com
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
1 month ago · defenseworld.net
Ballast Inc. Makes New Investment in Elevance Health, Inc. $ELVBallast Inc. acquired a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 1,572 shares of the company's stock, valued at approximately $608,000. A number of other institutional investors and hedge funds
2 months ago · businesswire.com
Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health JourneyINDIANAPOLIS--(BUSINESS WIRE)--Cancer care is often overwhelming, not just medically, but emotionally and logistically. Elevance Health is strengthening its connected cancer care model to enhance support consumers receive throughout their care journeys, with a focus on earlier support, personalized care navigation, and more coordinated care.Each year in the U.S., 1.8 million people are diagnosed with cancer. For many patients, a cancer diagnosis brings not only medical decisions, but also a comp.
2 months ago · defenseworld.net
Elevance Health, Inc. $ELV Shares Acquired by AmundiAmundi increased its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 145.7% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,693,664 shares of the company's stock after purchasing an additional 1,597,497 shares during the period. Amundi owned 1.24%
2 months ago · 247wallst.com
Stock Market Live July 28, 2028: S&P 500 (SPY) Struggling to Stay GreenTech stocks are dragging the Nasdaq lower while the Federal Reserve kicks off a critical policy meeting, and one major CEO just spent a million dollars buying into a stock the market punished after earnings.
2 months ago · defenseworld.net
Bessemer Group Inc. Has $1.26 Million Holdings in Elevance Health, Inc. $ELVBessemer Group Inc. lessened its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 97.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,297 shares of the company's stock after selling 138,897 shares during the quarter. Bessemer Group Inc.'s
2 months ago · defenseworld.net
Elevance Health, Inc. (NYSE:ELV) Given Consensus Rating of “Moderate Buy” by BrokeragesShares of Elevance Health, Inc. (NYSE: ELV - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-three ratings firms that are covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ELV